Effective September 26, 2007: license requirements for strains using "Cre-lox" technology only apply in Canada
Use of the "Cre-lox" mice only requires a license from either DuPont or Bristol-Myers Squibb Company if used by organizations with shipping or billing addresses in Canada. Contact information for Bristol-Myers Squibb and DuPont is given below and is also available from applicable Strain data sheets on the JAX® Mice Database on this Web site. If your company or institution already holds a license for use of "Cre-lox" mice (see *Note below), your order will be released immediately.
Mice subject to Canadian Patent CA1293460 are identified as “Cre-lox Animals” mice in the JAX® Mice Price List, Catalog, and web pages. Bristol-Myers Squibb and DuPont have certain rights to grant licenses under CA1293460 to use "Cre-lox Animals." The Jackson Laboratory may only distribute mice to companies and institutions that hold a license from Bristol-Myers Squibb or DuPont (see *Note below).
Licensing information may be obtained by contacting:
|
Debra Desmond |
OR | Drew E. Van Dyk DuPont Intellectual Assets & Licensing DuPont Experimental Station Rt. 141 and Henry Clay Wilmington, DE 19880-0268 USA Tel: 877-881-9787 Fax: 302-695-1437 Email: drew.e.van-dyk@usa.dupont.com |
*Note: Companies and Institutions that already hold a current license under CA1293460 from:
- DuPont Pharmaceuticals Company,
- The DuPont Merck Pharmaceutical Company, or
- E. I. DuPont de Nemours and Company,
may purchase "Cre-lox" mice and do not need to contact Bristol-Myers Squibb or DuPont for a license.
The use of any such "Cre-lox Animal" obtained from The Jackson Laboratory shall be subject to all the terms and conditions of the applicable license. The sale of "Cre-lox Animals" by The Jackson Laboratory is not meant to carry with it, and does not grant any license, expressed or implied, under any patent.
Institutions that have funding agreements with the Public Health Service of the U.S. Department of Health and Human Services (PHS) are directed to a Memorandum of Understanding between PHS and DuPont regarding the terms and conditions for the use of these mice. http://ott.od.nih.gov/cre-lox.html
